{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4069"}, "official-title": {"#tail": "\n\t", "#text": "To improve enforcement efforts related to prescription drug diversion and abuse, and for other\n\t\t\t purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140218", "#text": "February 18, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committee on the ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such\n\t\t\t provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HJU00", "#text": "Judiciary"}], "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Marino", "@name-id": "M001179"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mrs. Blackburn", "@name-id": "B001243"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HB8005B8013634313AF438501BB7F9766", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": "\n        ", "@entity-type": "act", "@value": "Ensuring Patient Access and Effective Drug Enforcement Act of 2013", "short-title": {"#tail": "\n          ", "#text": "Ensuring Patient Access and Effective Drug Enforcement Act of 2013"}, "#text": "\n            "}, "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HA9E51FEC3C894D3F925F6A03B3AEB01A"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Registration process under Controlled Substances Act"}, "subsection": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the\n\t\t\t following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 303 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:303"}, {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "\n                  ", "external-xref": {"#tail": "\n                ", "@parsable-cite": "usc/21/823", "#text": "21 U.S.C. 823", "@legal-doc": "usc"}, "@value": "usc/21/823"}, "@entity-type": "uscode", "#text": "\n                ", "@value": "usc/21/823"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Consistent with the public health and safety"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "subsection": {"#tail": "\n            ", "text": {"#tail": "\n            ", "quote": {"#tail": " means having a substantial relationship to this Act\u2019s purpose of preventing diversion and abuse of\n\t\t\t controlled substances.", "#text": "consistent with the public health and safety"}, "#text": "In this section, the phrase ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "@id": "HEB2E82BBA43245EA987874195798D564", "#text": "\n              "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H19D2F9DDD34344739CAF572A15699DC3"}, "#text": "\n          ", "@id": "HE66167E3A57C45A6B770BC1C301ABBCA"}, {"#tail": "\n      ", "@id": "H8A91251B948A455DB3B04D403BD0D572", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Imminent danger"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 304(d) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:304/ss:d"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 824(d)", "@value": "usc/21/824/d"}, "@parsable-cite": "usc/21/824", "#text": "\n                ", "@legal-doc": "usc"}}}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "\n                (d) The Attorney General"}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " The Attorney General", "@entity-type": "act", "#text": "(d)(1)", "@value": "Controlled Substances Act/s:304/ss:d/p:1"}, "#text": "\n                "}], "#text": "by striking "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HDE022EB0D0DC46DB860CACBA729D2159", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "paragraph": {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the term ", "@entity-type": "act", "#text": "this subsection", "@value": "Controlled Substances Act/s:304/ss:d"}, "term": {"#tail": " means a significant and present risk of death or serious bodily harm that is more likely than not\n\t\t\t to occur in the absence of an immediate suspension order.", "#text": "imminent danger"}, "#text": "In ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "#text": "\n                ", "@id": "HF208FE0F955A4D078378A647415EBDB5"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "HF7AB5E690F79405AABFF9104D40D59D6"}, "#text": "\n            ", "@id": "H37975DE457284496846318BE3478E746"}]}], "#text": "\n        ", "@id": "H91BA2ECC8582417B9880E845AB56A99D"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Criminal background checks and drug testing for employees with access to controlled substances"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (as added by ", "@entity-type": "act", "#text": "subsection (j)", "@value": "Controlled Substances Act/s:303/ss:j"}, {"#tail": ") the following:", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Ensuring Patient Access and Effective Drug Enforcement Act of 2013/s:2/ss:a/p:1", "@proposed": "true"}], "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by inserting before\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 303 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:303"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 823", "@value": "usc/21/823"}, "@parsable-cite": "usc/21/823", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Requirements"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "subsection": {"#tail": "\n            ", "#text": "\n              ", "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(i)"}, "@id": "HA9ECDA3C268249479B5961937627F805", "paragraph": [{"@id": "H34CDCC171E7D4F789CA4AB8CA359B170", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall require all registrants under ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": ", as a\n\t\t\t condition of such registration\u2014", "@entity-type": "act", "#text": "subsections (a), (b), (d), or (e)", "@value": "Controlled Substances Act/s:303/ss:a, b, d, e"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "subparagraph": [{"@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to obtain a criminal background check on each of the registrant\u2019s employees who has or will have\n\t\t\t access to facility areas where controlled substances under the\n\t\t\t registrant\u2019s possession or control are stored, such as a cage, vault, or\n\t\t\t safe; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                  ", "@id": "HA8C907C7AA8D490CBD911BCF1A010188"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to perform drug testing on each such employee in accordance with Federal and State law.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "HC52243997B4A4C43BD9A4438D7D038B7"}], "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be obtained\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Controlled Substances Act/s:303/ss:i/p:1", "@proposed": "true"}, "#text": "The criminal background checks required by "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "#text": "\n                ", "@id": "H45115C612BCB465F8BE7E59938393F56", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "paragraph (1)(A)", "@value": "Controlled Substances Act/s:303/ss:i/p:1/sp:A", "@proposed": "true"}, "#text": "periodically, but not more frequently than every 2 years, for all employees of the registrant who\n\t\t\t are described in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HD8B682F9762F4758B2702A54FDF8F339", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ".", "@entity-type": "act", "@value": "Ensuring Patient Access and Effective Drug Enforcement Act of 2013", "short-title": {"#tail": "\n                    ", "#text": "Ensuring Patient Access and Effective Drug Enforcement Act of 2013"}, "#text": "\n                      "}, "#text": "at the time of hire, for such employees who are hired after the date of enactment of the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H1F40F4AB03FE499DBC87CEB038DB8927", "#text": "\n                  "}]}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n              ", "term": {"#tail": " means testing designed to detect the illegal use of a controlled substance.", "#text": "drug testing"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "#text": "\n                ", "@id": "H206D57C4BEFF43F8B61F1B0A63226534"}]}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H305C285C0AC14C1B83334903F998018F"}, "#text": "\n          ", "@id": "H078E9B3AD6614CD087B1ADB88B965142"}, {"#tail": "\n        ", "@id": "HD0324B20F72545EDA812CBE1EFBBF6E6", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Conforming change"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 304(a) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:304/ss:a"}, {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "uscode", "#text": "\n                    ", "external-xref": {"#tail": "\n                  ", "@parsable-cite": "usc/21/823", "#text": "21 U.S.C. 823(a)", "@legal-doc": "usc"}, "@value": "usc/21/823/a"}, "@entity-type": "uscode", "#text": "\n                  ", "@value": "usc/21/823/a"}, "@entity-type": "uscode", "#text": "\n                ", "@value": "usc/21/823/a"}], "@entity-type": "law-citation", "#text": "\n              "}}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Controlled Substances Act/s:304/ss:a/p:4"}, "#text": "in ", "quote": {"#tail": " at the end;", "#text": "or"}}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H06121AD6B7EF4D3A85DC7F25D834D78B", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking the period at the end and inserting ", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Controlled Substances Act/s:304/ss:a/p:5"}, "#text": "in ", "quote": {"#tail": "; and", "#text": "; or"}}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H2C824B7CD2A44E1C82637EABEF9E1DF5", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "paragraph": {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to criminal background\n\t\t\t checks and drug testing).", "@entity-type": "act", "#text": "section 303(i)", "@value": "Controlled Substances Act/s:303/ss:i", "@proposed": "true"}, "#text": "has failed to comply with the requirements under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "@id": "HF9C41D6534CD4BBE9FE2E3AFC3B22A6D", "#text": "\n                "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "HC8B861B0D9064258BB33B9E75BA5D2C4"}, "#text": "\n            ", "@id": "H08160EC15DC144D98857F3073258E147"}]}, {"#tail": "\n        ", "subparagraph": [{"#tail": "\n          ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "paragraph (14)", "@value": "Controlled Substances Act/s:402/ss:a/p:14"}, "#text": "in ", "quote": {"#tail": " at the end;", "#text": "or"}}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "HF91C828BFF1D4683A69CB9900C715196", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking the period at the end and inserting ", "@entity-type": "act", "#text": "paragraph (15)", "@value": "Controlled Substances Act/s:402/ss:a/p:15"}, "#text": "in ", "quote": {"#tail": "; and", "#text": "; or"}}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "HD0EB7EC205304311A6C55C4C494474A9", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the following:", "@entity-type": "act", "#text": "paragraph (15)", "@value": "Controlled Substances Act/s:402/ss:a/p:15"}, "#text": "by inserting after "}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n              ", "#text": "."}, "#tail": "\n\t\t\t\t\t\t", "paragraph": {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to\n\t\t\t criminal background checks and drug testing);", "@entity-type": "act", "#text": "section 303(i)", "@value": "Controlled Substances Act/s:303/ss:i", "@proposed": "true"}, "#text": "who is a registrant to fail to comply with the requirements under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(16)"}, "@id": "H877B369462C94A45AD12E35ED8261764", "#text": "\n                  "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t\t", "@id": "H25EFED54F00E4E12981E740BF90CC5B8"}, "#text": "\n              ", "@id": "H50E6D1346E5C47379EBBE3F12588A730"}], "enum": {"#tail": "\n            ", "#text": "(A)"}, "header": {"#tail": "\n            ", "#text": "Prohibited act"}, "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 402(a) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:402/ss:a"}, {"#tail": ")", "@entity-type": "uscode", "#text": "\n                  ", "external-xref": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "uscode", "#text": "21 U.S.C. 842(a)", "@value": "usc/21/842/a"}, "@parsable-cite": "usc/21/842", "#text": "\n                    ", "@legal-doc": "usc"}, "@value": "usc/21/842/a"}], "@entity-type": "law-citation", "#text": "\n                "}}, "#text": "\n            ", "@id": "HD4EA20F2F0C24867BF657066E4398C4B"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "\n                paragraph (5) or (10)\n              "}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Controlled Substances Act/s:402/ss:c/p:5"}, {"#tail": ", or ", "@entity-type": "act", "#text": "(10)", "@value": "Controlled Substances Act/s:402/ss:c/p:10"}, {"#tail": "\n              ", "@entity-type": "act", "#text": "(16)", "@value": "Controlled Substances Act/s:402/ss:c/p:16", "@proposed": "true"}], "#text": "\n                "}], "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t striking ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Subsection (c)(1)(B) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:402/ss:c/p:1/sp:B"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "uscode", "#text": "21 U.S.C. 842(c)(1)(B)", "@value": "usc/21/842/c/1/B"}, "@parsable-cite": "usc/21/842", "#text": "\n                  ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "header": {"#tail": "\n            ", "#text": "Maximum civil penalty of $10,000"}, "#text": "\n            ", "@id": "H9D5EA3C681D7423A902DECF1F70500CA"}], "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Alternative civil penalty for failure To comply with criminal background check and drug testing\n\t\t\t requirements"}, "#text": "\n          ", "@id": "H6C1B84D5C24E4DC8BDE7EF3E753E0061"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of the United States shall finalize such regulations and guidance as the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": " deems necessary to carry out the amendments made by this\n\t\t\t subsection.", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}], "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "header": {"#tail": "\n          ", "#text": "Regulations, guidance"}, "#text": "\n          ", "@id": "H08608286A3744C7392D2C484DD8FD783"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "The amendments made by this subsection shall apply beginning on the date that is 2 years after the\n\t\t\t date of enactment of this Act."}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "header": {"#tail": "\n          ", "#text": "Applicability"}, "#text": "\n          ", "@id": "H1D2DE76F6FEF4B279BE66430FCD72483"}], "#text": "\n        ", "@id": "H592DF4C2D9534E04AEBEC5F032FF6F8E"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 304(c) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:304/ss:c"}, {"#tail": ")", "@entity-type": "uscode", "#text": "\n              ", "external-xref": {"#tail": "\n            ", "@parsable-cite": "usc/21/824", "#text": "21 U.S.C. 824(c)", "@legal-doc": "usc"}, "@value": "usc/21/824/c"}], "@entity-type": "law-citation", "#text": "\n            "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Opportunity To submit corrective action plan prior to revocation or suspension"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "\n              (c) Before"}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " Before", "@entity-type": "act", "#text": "(c)(1)", "@value": "Controlled Substances Act/s:304/ss:c/p:1"}, "#text": "\n              "}], "#text": "by striking "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H05D88B6EA15B4757BC422059CB070981", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "paragraph": {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "section 303", "@value": "Controlled Substances Act/s:303"}, {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}], "#text": "Before revoking or suspending a registration pursuant to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "H6DFCC00934A74A528CDF52621C2EA9BB", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "notice to the registrant of the grounds for revocation or suspension; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H67CFA29D732B4CAABFCF929EEC4C7A55", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "in the case of any such grounds consisting of a violation of law, a specific citation to such law;"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "HA420E0BDADA843B5B14C3622076C2E3A", "#text": "\n                  "}], "#text": "\n                ", "@id": "HFB3A5233B88144EA97F8949DDAE37487"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "give the registrant an opportunity to submit a corrective action plan within a reasonable period of\n\t\t\t time to demonstrate how the registrant plans to correct the grounds for\n\t\t\t revocation or suspension; and"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HD3C48F76F81F4FB382B747D769D2F112", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "determine whether\u2014"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "in light of the plan, revocation or suspension proceedings should be discontinued or deferred; or"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H876A31931F2249CE84DDC306DDD4740E", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "additional changes need to be made in the corrective action plan."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H04FA26F9F7964B6DA085FEF2C2326B66", "#text": "\n                  "}], "#text": "\n                ", "@id": "HA9CEB95DA48F410EB851B5E92C2993FD"}]}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H38FA68A5935F45ABA17C252773A843C8"}, "#text": "\n          ", "@id": "HD15370C040CE46C180276E0125E7B9DF"}], "#text": "\n        ", "@id": "HF732DB8F0C9F4ACE90943AB43ABE74A9"}], "#text": "\n      ", "@id": "H33E2EC8878C24BCCA891ADEF97893D64"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Combating Prescription Drug Abuse Working Group"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (referred to in this\n\t\t\t section as the ", "@entity-type": "federal-body", "#text": "Combating Prescription Drug Abuse Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "quote": {"#tail": ").", "#text": "Working Group"}, "#text": "There is established the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Establishment"}, "#text": "\n        ", "@id": "H0427408361C74919AF2BE16CF6FDED0A"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Membership"}, "paragraph": [{"#tail": "\n        ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "#text": "Not later than 180 days after the date of the enactment of this Act, the President shall appoint\n\t\t\t each member of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "header": {"#tail": "\n            ", "#text": "In general"}, "#text": "\n            ", "@id": "HDD6FFA010E244B6AA47B573D95809346"}, {"#tail": "\n        ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Public policy experts.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "HE1B517BCBB44436CB6879F5B3EF077A3", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Drug Enforcement Administration", "@entity-id": "1524"}, "#text": "Representatives of the "}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "HD80F4D82C2C840359CF4C88F1BBEB3E8", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "Representatives of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "@id": "HEF333CD9C4EB44B49873B1FA3D8C9A2A", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-parent-id": "1100", "@entity-type": "federal-body", "#text": "Office of National Drug Control Policy"}, "#text": "Representatives of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(iv)"}, "@id": "H2D3C7DA0D6C84BA8A2ED1A69E9612D1B", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Representatives of patient groups.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(v)"}, "@id": "HE61EF98AB90F48BE9747CFF0259E5987", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Representatives of pharmacies.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(vi)"}, "@id": "HF36E82D9DABE49469168F766D525D07B", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Representatives of manufacturers of drugs."}, "enum": {"#tail": "\n              ", "#text": "(vii)"}, "@id": "H570DFDF2831B4D119AE7AD177BC8DB78", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Representatives of wholesale distributors of drugs."}, "enum": {"#tail": "\n              ", "#text": "(viii)"}, "@id": "HE445087361B541D8BDB89457F5855033", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Representatives of hospitals, physicians, and other health care providers."}, "enum": {"#tail": "\n              ", "#text": "(ix)"}, "@id": "H48267B0E68D343659FE2685FFAA8F1B5", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Representatives of State attorneys general.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(x)"}, "@id": "H870F3503D3D34650A5A513B77C5077DF", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Representatives of law enforcement officials, including local law enforcement officials.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(xi)"}, "@id": "HFDEF39F4C8824DB983246411B7E27280", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Representatives of health benefits plans and entities that provide pharmacy benefits management\n\t\t\t services on behalf of a health benefits plans.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(xii)"}, "@id": "HA206F1F44F134711A2EEBCA9A425D27E", "#text": "\n              "}], "enum": {"#tail": "\n            ", "#text": "(B)"}, "header": {"#tail": "\n            ", "#text": "Composition"}, "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be composed of not more than 20 members and shall include at least 1 and\n\t\t\t not more than 3 of each of the following:", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "#text": "The "}, "#text": "\n            ", "@id": "H4DAFEBBBB4864DB091C7861B7BBBA8B4"}], "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Appointment"}, "#text": "\n          ", "@id": "H1517A06750BD47759519D3458B95BC9C"}, {"#tail": "\n        ", "@id": "H4D0397123D0C4F4A85DCAF7647B5C16A", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Co-chairs"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ". The Working Group shall select\n\t\t\t for election from the members of the Group two individuals, of whom\u2014", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "#text": "The co-chairs shall be elected by the members of the ", "@display-inline": "yes-display-inline"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "one shall be a representative of the Federal Government or a State government; and"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H77E926CF19D24620A0ACA7FE968CCF20", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "one shall be a representative of a non-governmental entity."}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H7A6C32EC882E4AECB2A61ACD6E6A7491", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ". Any vacancy in the Working Group\n\t\t\t shall not affect the powers of the Working Group and shall be filled in\n\t\t\t the same manner in which the original appointment was made.", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "#text": "Each member shall be appointed for the life of the "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Term; vacancies"}, "#text": "\n          ", "@id": "HC0092BAE35E345F389C630FC66842582"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall serve without pay.", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "#text": "Members of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "header": {"#tail": "\n          ", "#text": "Pay prohibited"}, "#text": "\n          ", "@id": "HA9399C3DF0134CF3B24F1407C9A27544"}], "#text": "\n        ", "@id": "H624701A4EF70405EA673F5899C54A3C1"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall meet at the call of the co-chairs. The Working Group shall conduct at least\n\t\t\t two public meetings, at which the Working Group shall provide opportunity\n\t\t\t for public comment.", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Meetings"}, "#text": "\n        ", "@id": "H9EBCDEA7F55046ACA882D4F9A3B358F0"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Duties of the Working Group"}, "paragraph": [{"#tail": "\n        ", "@id": "H3DE843E494F04EFD94362DA24D3D1F44", "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "#text": "The "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " on Federal initiatives with respect to efforts to reduce prescription\n\t\t\t drug diversion and abuse;", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "review and report to "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H42173077C4364977A80F55D7CAEC70AB", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "identify gaps and opportunities with respect to ensuring the safe use of prescription drugs with\n\t\t\t the potential for diversion and abuse;"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H0669898CDDCE4FB6909D2FFD802DC033", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "examine recommendations to transfer one or more controlled substances from schedule III to schedule\n\t\t\t II under the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " to\n\t\t\t evaluate\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Controlled Substances Act", "@value": "Controlled Substances Act"}, {"#tail": ")", "@entity-type": "uscode", "#text": "\n                  ", "external-xref": {"#tail": "\n                ", "@parsable-cite": "usc/21/801", "#text": "21 U.S.C. 801 et seq.", "@legal-doc": "usc"}, "@value": "usc/21/801/etseq"}], "@entity-type": "law-citation", "#text": "\n                "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the effectiveness of such a transfer in reducing diversion and abuse; and"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "H90007DCA17E948629C2BA77B538E16C6", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "any effect of such a transfer on access to prescription drugs for legitimate medical purposes; and"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H7B4E80E67B6040AC883E99762270FCE1", "#text": "\n              "}], "#text": "\n            ", "@id": "HF2CFA43BC6484406B83BF66200C38722"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "make recommendations on specific ways to reduce the diversion and abuse of prescription drugs."}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "@id": "H8B7A14687BE945669B1281BB5C7124E2", "#text": "\n            "}]}, {"#tail": "\n      ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall issue\n\t\t\t a report to ", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, {"#tail": " that describes the efforts of the Working Group to\n\t\t\t prevent or reduce prescription drug diversion and abuse to ensure that\n\t\t\t patients continue to have access to medications.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Not later than one year after the date of the enactment of this Act, the "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "header": {"#tail": "\n            ", "#text": "In general"}, "#text": "\n            ", "@id": "H9CDD58051C794FC4B946800736D9AB87"}, {"#tail": "\n        ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Systems for prescription drug monitoring."}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "H8C5174E5D72145939380F656E9529852", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Illegal prescription drug Internet sites and facilities that distribute and fill prescriptions\n\t\t\t indiscriminately.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H446FC28D1BD245A5B49E6A4E7B17E5DE", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Facilitating proper disposal of prescription drugs."}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "@id": "HB08A0C8535B242D59699D71C42B090BC", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Identifying active geographic areas in which prescription drug abuse is prevalent."}, "enum": {"#tail": "\n              ", "#text": "(iv)"}, "@id": "HC9AD27E5C2454B2F8F4F38601EA040B2", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Ensuring access to prescription drugs for legitimate medical purposes.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(v)"}, "@id": "HF3F39556595848B5A41B04FC667DA0CF", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and\n\t\t\t the ", "@entity-type": "federal-body", "#text": "Drug Enforcement Administration", "@entity-id": "1524"}, {"#tail": ", for purposes of coordinating prevention\n\t\t\t and enforcement efforts to reduce prescription drug diversion and abuse.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Improving collaboration among Federal agencies, especially the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(vi)"}, "@id": "H9573C87EB2134ABCAB91E0EA3C509039", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Improving collaboration among Federal agencies and State agencies for purposes of coordinating\n\t\t\t prevention and enforcement efforts to reduce prescription drug diversion\n\t\t\t and abuse."}, "enum": {"#tail": "\n              ", "#text": "(vii)"}, "@id": "HF887B7B36F0348ECB072F6A8EAF66349", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The resource needs for law enforcement with respect to prescription drug abuse."}, "enum": {"#tail": "\n              ", "#text": "(viii)"}, "@id": "H4F3EA94D102940EA8E7FF96C7E7EBD31", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The need for education of providers, patients, parents, and youth on prescription drug abuse."}, "enum": {"#tail": "\n              ", "#text": "(ix)"}, "@id": "H1992E11484254CA39C120543D2E3E50D", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Development of abuse-resistant prescription drug products."}, "enum": {"#tail": "\n              ", "#text": "(x)"}, "@id": "HA23943D6C5184CD3AB6C62308BBA69F3", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Recommendations for reducing robberies, burglaries, and cargo theft of prescription drugs."}, "enum": {"#tail": "\n              ", "#text": "(xi)"}, "@id": "HD9AFD518483A42A296A58779A180AB17", "#text": "\n              "}], "enum": {"#tail": "\n            ", "#text": "(B)"}, "header": {"#tail": "\n            ", "#text": "Recommendations"}, "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall include specific recommendations for the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Ensuring Patient Access and Effective Drug Enforcement Act of 2013/s:3/ss:d/p:2/sp:A", "@proposed": "true"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Drug\n\t\t\t Enforcement Administration", "@entity-id": "1524"}, {"#tail": ", and other\n\t\t\t Federal and State agencies, as appropriate, and shall address the\n\t\t\t following topics:", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "The report described in "}, "#text": "\n            ", "@id": "H94EC3C8E34F54112A29F329DF85AEC0E"}], "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Report"}, "#text": "\n          ", "@id": "H46AF2F2EB99E4B99849B42B9A9ECF6B7"}], "#text": "\n        ", "@id": "HDBE979CF79754AD09B9ADA446AF4718C"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Powers of the Working Group"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may, for the purpose of carrying out this section, hold hearings, sit and act at\n\t\t\t times and places, take testimony, and receive evidence as the Working\n\t\t\t Group considers necessary.", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Hearings"}, "#text": "\n          ", "@id": "HD1408E1E819F4619B2FB5B18613FC3FE"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may secure directly from any Federal department or agency such information as the\n\t\t\t Working Group considers necessary to carry out this section. Upon the\n\t\t\t request of the co-chairs of the Working Group, the head of such department\n\t\t\t or agency shall furnish such information to the Working Group in a timely\n\t\t\t manner.", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Information from Federal agencies"}, "#text": "\n          ", "@id": "HE33280DB1B6E420BB271176C419FFF92"}], "#text": "\n        ", "@id": "H53F7FFE9C0A24B87953396C3465143BC"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall terminate two years after the date on which the members are appointed under\n\t\t\t ", "@entity-type": "federal-body", "#text": "Working Group", "@value": "Combating Prescription Drug Abuse Working Group", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)", "@value": "Ensuring Patient Access and Effective Drug Enforcement Act of 2013/s:3/ss:b", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(f)"}, "header": {"#tail": "\n        ", "#text": "Termination of the Working Group"}, "#text": "\n        ", "@id": "H52A92FC5BA6F4AA48470B6FC29C7D379"}], "#text": "\n      ", "@id": "H0E8B4F61EF83486491380004A4E7C0ED"}], "#text": "\n\t\t", "@id": "H60066D02155940B589F896F608A11386"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-02-18"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4069 IH: Ensuring Patient Access and Effective Drug Enforcement Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}